--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About NRXP20261218C2.5
Chemical and pharmaceutical
NRx Pharmaceuticals, Inc., was incorporated on May 20, 2015 under the laws of the State of Delaware. The Company is a clinical-stage biopharmaceutical company that, through its wholly-owned operating subsidiary, NeuroRx, Inc., develops and distributes novel therapies for the treatment of central nervous system diseases, including suicidal depression, chronic pain, post-traumatic stress disorder and now schizophrenia.
